Weight Loss Peptides
Research peptides studied for their effects on appetite regulation, metabolic rate, and body composition.
Research-Grade Weight Loss Peptides
Research-grade compounds from Peptides Looksmaxxing. >98% purity, CoA on request.
Retatrutide
Buy Retatrutide 10mg online — research-grade lyophilized peptide for laboratory use. Triple GLP-1/GIP/Glucagon receptor agonist. ≥98% HPLC purity verified.
CAS: 2381089-83-2
Tirzepatide
Buy Tirzepatide 15mg online — research-grade lyophilized peptide for laboratory use. 39-amino-acid synthetic peptide with C20 fatty diacid modification. ≥98% HPLC purity verified.
CAS: 2023788-19-2
Semaglutide
Buy Semaglutide 3mg online — research-grade lyophilized peptide for laboratory use. GLP-1 receptor agonist (31-amino acid lipidated peptide). ≥98% HPLC purity verified.
CAS: 910463-68-2
Cagrilintide
Buy Cagrilintide 5mg online — research-grade lyophilized peptide for laboratory use. Long-acting amylin analog. ≥98% HPLC purity verified.
CAS: 1415456-99-3
Cagri-Reta
Buy Cagri-Reta 5mg online — research-grade lyophilized peptide for laboratory use. ≥98% HPLC purity verified.
Cagri-Sema Blend
Buy Cagri-Sema Blend 10mg online — research-grade lyophilized peptide for laboratory use. Long-acting amylin analog. ≥98% HPLC purity verified.
CAS: 1415456-99-3
Reta-Cagri
Buy Reta-Cagri 5mg/5mg online — research-grade lyophilized peptide for laboratory use. ≥98% HPLC purity verified.
Weight Loss Peptides: A Research Overview
GLP-1 receptor agonists represent one of the most significant advances in metabolic research. These peptides mimic the incretin hormone glucagon-like peptide-1, which plays a crucial role in glucose homeostasis and appetite regulation.
Mechanism of Action
GLP-1 receptor agonists work by binding to GLP-1 receptors in the pancreas and brain. In the pancreas, they stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner. In the hypothalamus, they activate satiety centers, reducing appetite and food intake.
Key Peptides in This Category
Semaglutide (GLP-1 S) Semaglutide is a synthetic GLP-1 analog with a C18 fatty diacid side chain that enables albumin binding, extending its half-life significantly. Research has demonstrated its efficacy in reducing body weight by 15-17% in clinical trials (STEP trials). It acts primarily through GLP-1 receptor activation.
Tirzepatide (GLP-2 T) Tirzepatide is a dual GIP/GLP-1 receptor agonist — the first of its kind. By activating both incretin receptors, it produces enhanced metabolic effects compared to selective GLP-1 agonists alone. The SURMOUNT clinical trials demonstrated weight reductions of up to 22.5% from baseline. Its 39-amino acid structure includes a C20 fatty diacid modification for extended duration of action.
Retatrutide (GLP-3 R) Retatrutide is a triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This novel triple-agonist approach addresses multiple metabolic pathways. Phase 2 trial data showed unprecedented weight loss of up to 24% at 48 weeks. The glucagon receptor component may provide additional benefits through increased energy expenditure and hepatic lipid metabolism.
Research Applications
- Metabolic syndrome studies
- Appetite regulation mechanisms
- Glucose homeostasis research
- Body composition analysis
- Cardiovascular outcome studies
Comparative Analysis
| Peptide | Receptor Targets | Mechanism | Research Weight Loss |
| Semaglutide | GLP-1 | Single agonist | ~15-17% |
| Tirzepatide | GIP + GLP-1 | Dual agonist | ~20-22.5% |
| Retatrutide | GIP + GLP-1 + Glucagon | Triple agonist | ~24% |
Research Context
Retatrutide leads the current wave of GLP-1/GIP/glucagon tri-agonist research for metabolic reprogramming. Unlike earlier single-agonist molecules, the triple mechanism targets energy homeostasis from three angles simultaneously — making it the most studied compound for body-composition shifts in the current literature.
Mechanism Overview
Molecular mechanisms behind weight loss peptides research
GLP-1R Appetite Suppression
GLP-1 receptor agonists activate hypothalamic POMC/CART neurons and area postrema GLP-1 receptors — suppressing appetite, slowing gastric emptying, and extending satiety. This is the shared mechanism across semaglutide, tirzepatide, and Retatrutide.
Glucagon Receptor Fat Oxidation
Retatrutide's unique glucagon receptor engagement drives hepatic beta-oxidation — the liver burns stored fat directly, independent of appetite. GcgR activation in brown adipose tissue also increases thermogenesis. This is why Retatrutide's Phase 2 data (-28.7%) far exceeds single or dual agonists.
GIP Receptor Insulin Sensitization
GIP receptor agonism enhances peripheral insulin sensitivity and drives direct adipocyte lipid metabolism effects. In combination with GLP-1, GIP synergistically potentiates GLP-1 receptor signaling — explaining why dual and triple agonists outperform GLP-1 alone.
Research-Grade Weight Loss Peptides
>98% purity, third-party tested. Free shipping on orders over $200.
Suggested Stacks
Suggested compound combinations for weight loss peptides research
Clavicular Core Stack
Triple-agonist fat loss + GI protection + skin remodeling. The Clavicular Stack design: Retatrutide burns fat via 3 pathways; BPC-157 protects against GLP GI effects; GHK-Cu delivers the GLOW outcome.
Budget Entry Stack
Tirzepatide (dual GLP-1/GIP) at -20.9% Phase 3 weight loss paired with BPC-157 for GI protection. The best-value starting point for GLP research before escalating to triple-agonist Retatrutide.
Clinical Data
Published studies underpinning weight loss peptides
New England Journal of Medicine
Retatrutide (triple GLP-1/GIP/Glucagon agonist) Phase 2 trial: mean -28.7% body weight at 48 weeks at 8mg dose — largest Phase 2 weight loss result ever recorded for a GLP compound.
Jastreboff A.M. et al.
New England Journal of Medicine
Semaglutide 2.4mg achieved -14.9% mean body weight at 68 weeks vs. -2.4% placebo in 1,961 adults with obesity — establishing the first GLP-1 agonist as a major obesity treatment.
Wilding J.P.H. et al. (STEP 1)
New England Journal of Medicine
Tirzepatide (dual GLP-1/GIP) achieved -20.9% mean body weight at 72 weeks at 15mg — surpassing semaglutide and validating dual incretin receptor engagement as superior to GLP-1 alone.
Jastreboff A.M. et al. (SURMOUNT-1)
Related Research
Articles and breakdowns for weight loss peptides
9
The Venus Protocol: Women's Looksmaxxing Peptide Stack 2026
The Venus Protocol is the first comprehensive peptide stack designed specifically for feminine aesthetic optimization — combining GHK-Cu for skin transformation, Semaglutide for metabolic reshaping, BPC-157 for gut healing, and SNAP-8 for anti-aging. Here's the complete breakdown.
Read more11
Clavicular Ascension Stack: The Ultimate 12-Compound Looksmaxxing Protocol
The Clavicular Ascension Stack is the evolution of Clav's basic protocol — a 12-compound, 5-pillar system covering fat loss, skin, recovery, muscle and GH axis, and metabolic optimization. For experienced researchers who have already run the fundamentals, this is the ceiling.
Read moreLooking for Clavicular's Looksmaxxing Stack?
See which peptides Clavicular uses in his viral looksmaxxing transformation — Retatrutide, BPC-157, and more.
Category Q&A
What are GLP-1 receptor agonists?
GLP-1 receptor agonists are synthetic peptides that mimic the natural incretin hormone glucagon-like peptide-1. They bind to GLP-1 receptors in the pancreas and brain, affecting insulin secretion, glucagon suppression, and appetite regulation.
How does Tirzepatide differ from Semaglutide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist, while Semaglutide targets only the GLP-1 receptor. This dual mechanism allows Tirzepatide to activate both incretin pathways simultaneously, which research suggests may produce enhanced metabolic effects.
What is Retatrutide?
Retatrutide is a novel triple hormone receptor agonist that targets GIP, GLP-1, and glucagon receptors simultaneously. It represents the latest generation of incretin-based peptides being studied for metabolic research applications.
What forms do these peptides come in?
Research peptides are typically supplied as lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before use in laboratory settings.
Shop Weight Loss Peptides
Research-grade weight loss peptides from Peptides Looksmaxxing. Third-party tested, >98% purity guaranteed.